Today: 29 April 2026
Browse Category

NASDAQ:ENVB 10 December 2025

Top U.S. Stock Gainers After the Bell on December 10, 2025: ASPC, BBGI, ENVB, PLAB, IRBT, AHT Lead Fed‑Day Rally

Top U.S. Stock Gainers After the Bell on December 10, 2025: ASPC, BBGI, ENVB, PLAB, IRBT, AHT Lead Fed‑Day Rally

The Federal Reserve cut its benchmark rate by 25 basis points Wednesday, marking its third reduction of 2025. The Dow rose 1.05%, the S&P 500 gained 0.67%, and the Nasdaq added 0.33%. Small- and mid-cap stocks saw sharp moves, with Beasley Broadcast Group surging nearly 390%. After-hours trading kept ASPC and ENVB among the top gainers.
Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, BBGI, ENVB, PLAB, IRBT & AHT Rocket on Fed Day

Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, BBGI, ENVB, PLAB, IRBT & AHT Rocket on Fed Day

A SPAC III Acquisition Corp. surged 267% and Beasley Broadcast Group jumped 224% Wednesday, leading U.S. stock gainers as the S&P 500 stayed flat ahead of a key Federal Reserve decision. Enveric Biosciences rose 79% on patent news. The Fed is expected to cut rates by 25 basis points, with attention on its 2026 rate outlook.
Enveric Biosciences (ENVB) Stock Surges on Patent Win: News, Forecast & Analysis as of December 10, 2025

Enveric Biosciences (ENVB) Stock Surges on Patent Win: News, Forecast & Analysis as of December 10, 2025

Enveric Biosciences shares surged over 70% in after-hours trading December 9, reaching around $10.29 after closing at $5.92, following news of a U.S. patent allowance for its EVM301 mental-health drug series. Pre-market quotes early December 10 ranged from $10.48 to $12.45 amid heavy volatility. The stock had fallen about 90% over the past year. The new patent covers both composition and method-of-use claims.
10 December 2025
Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, ENVB, BDRX, HSPO, BRZE Surge Ahead of Fed Decision

Top U.S. Stock Gainers Today (Dec. 10, 2025): ASPC, ENVB, BDRX, HSPO, BRZE Surge Ahead of Fed Decision

A SPAC III Acquisition (ASPC) surged over 100% pre-market Dec. 10, trading between $25 and $31 after sharp gains in after-hours. Enveric Biosciences (ENVB) and Biodexa Pharmaceuticals (BDRX) also posted triple- and double-digit percentage gains. Major U.S. index futures were little changed ahead of the Federal Reserve’s final 2025 rate decision. Speculative micro-caps and SPACs led early trading volatility.
Top Pre‑Market Gainers Today, December 10, 2025: ASPC, ENVB, BDRX and APVO Lead Fed‑Day Frenzy

Top Pre‑Market Gainers Today, December 10, 2025: ASPC, ENVB, BDRX and APVO Lead Fed‑Day Frenzy

A SPAC III Acquisition Corp. surged over 219% pre-market Wednesday, leading U.S. gainers as traders await the Federal Reserve’s final 2025 policy decision. Nasdaq 100, S&P 500, and Dow futures ticked higher, while the 10-year Treasury yield hovered near 4.18%. Silver traded above $61 an ounce. Other top pre-market movers included Enveric Biosciences, Biodexa Pharmaceuticals, and Ashford Hospitality Trust.

Stock Market Today

  • VICI Properties: Is the Stock Undervalued After Recent Recovery?
    April 29, 2026, 4:56 AM EDT. VICI Properties (VICI) trades near $28.65 after a recent share price rebound. Despite a modest 7.7% gain over the past month, the stock has declined 5.7% over the past year, trailing peers. A discounted cash flow (DCF) analysis suggests the stock could be undervalued by 45.7%, projecting intrinsic value at $52.73 per share based on adjusted funds from operations and future cash flows. VICI's price-to-earnings ratio stands at 11.03, below sector averages, reflecting cautious market sentiment amid concerns over income stability and tenant quality. Investors reassessing VICI's exposure to gaming real estate and sale-leaseback deals might find value in this discrepancy, though longer-term performance has been uneven.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026
LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 4:56 AM EDT VICI Properties: Is the Stock Undervalued After Recent Recovery? April 29, 2026, 4:56 AM EDT. VICI Properties (VICI) trades near $28.65 after a recent share price rebound. Despite a modest 7.7% gain over the past month, the stock has declined 5.7% over the past year, trailing peers. A discounted cash flow (DCF) analysis suggests the stock could be undervalued by 45.7%, projecting intrinsic value at $52.73 per share based on adjusted funds from operations and future cash flows. VICI's price-to-earnings ratio stands at 11.03, below
AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
Go toTop